NYSE:MYOV
Myovant Sciences Ltd.
- Stock
Last Close
26.99
09/03 21:01
Market Cap
2.62B
Beta: 2.15
Volume Today
2.26M
Avg: 1.09M
PE Ratio
−14.22
PFCF: −9.69
Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 1.31M - | 5.10M 290.46% | ||||||
average payables | 1.66M - | 3.95M 137.52% | 7.80M 97.26% | 13.18M 68.96% | 16.57M 25.77% | 15.03M 9.31% | ||
average receivables | 500K - | 762K 52.40% | 262K 65.62% | 1.78M 581.30% | 13.72M 668.80% | |||
book value per share | 3.39 - | 0.63 81.31% | 0.06 89.78% | -1.26 2,047.39% | -3.93 211.67% | -5.09 29.54% | ||
capex per share | -0.02 - | -0.01 48.39% | -0.02 82.04% | -0.01 30.69% | -0.02 53.81% | -0.01 46.80% | ||
capex to depreciation | -15.85 - | -2.49 84.32% | -2.82 13.53% | -0.62 77.93% | -0.72 14.86% | -0.32 55.67% | ||
capex to operating cash flow | 0.05 - | 0.01 90.30% | 0.01 7.08% | 0.00 9.91% | -0.00 196.27% | 0.00 175.81% | ||
capex to revenue | -0.03 - | -0.00 85.89% | ||||||
cash per share | 3.68 - | 1.82 50.36% | 2.33 27.81% | 0.93 60.22% | 7.61 719.93% | 4.67 38.61% | ||
days of inventory on hand | 484.99 - | 53.70 88.93% | ||||||
days payables outstanding | 3.31K - | 86.73 97.38% | ||||||
days sales outstanding | 21.97 - | 37.73 71.76% | ||||||
debt to assets | 0.10 - | 0.68 584.17% | 0.97 42.70% | 2.02 107.42% | 1.49 26.41% | 1.91 28.38% | ||
debt to equity | -1 - | 0.11 111.09% | 2.16 1,844.08% | 38.91 1,704.18% | -1.98 105.08% | -3.05 54.09% | -2.10 31.17% | |
dividend yield | ||||||||
earnings yield | -0.14 - | -0.11 21.69% | -0.17 52.00% | -0.45 159.26% | -0.14 69.12% | -0.17 20.80% | ||
enterprise value | 396.59M - | 1.20B 202.83% | 1.53B 27.71% | 697.65M 54.51% | 1.55B 121.91% | 1.20B 22.51% | ||
enterprise value over ebitda | -4.75 - | -8.53 79.55% | -5.81 31.87% | -2.59 55.38% | -6.00 131.24% | -6.52 8.75% | ||
ev to operating cash flow | -21.77 - | -10.24 52.96% | -6.84 33.18% | -3.15 53.91% | 4.18 232.42% | -4.47 206.94% | ||
ev to sales | 26.10 - | 5.19 80.10% | ||||||
free cash flow per share | -0.39 - | -1.98 407.73% | -3.37 70.07% | -2.59 23.11% | 4.10 258.21% | -2.90 170.76% | ||
free cash flow yield | -0.03 - | -0.09 180.24% | -0.14 52.18% | -0.34 142.08% | 0.20 158.04% | -0.22 209.33% | ||
graham net net | 3.30 - | 0.47 85.75% | -0.18 138.68% | -1.57 761.44% | -4.33 176.38% | -5.78 33.46% | ||
graham number | 11.38 - | 5.86 48.50% | 2.44 58.34% | 9.77 300.45% | 15.83 61.97% | 15.93 0.64% | ||
income quality | 0.22 - | 0.82 274.94% | 0.82 0.08% | 0.77 6.57% | -1.45 289.81% | 1.30 189.75% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -68.95 - | -30.02 56.46% | -21.38 28.79% | -25.07 17.28% | -13.41 46.52% | |||
interest debt per share | 0.77 - | 1.62 110.76% | 1.62 0.04% | 4.22 160.94% | 4.11 2.71% | |||
inventory turnover | 0.75 - | 6.80 803.20% | ||||||
invested capital | 1.16 - | 22.93 1,883.21% | -1.17 105.08% | -1.04 10.40% | -0.78 25.61% | |||
market cap | 577.43M - | 1.27B 119.25% | 1.59B 25.63% | 648.09M 59.25% | 1.85B 185.91% | 1.24B 33.16% | ||
net current asset value | -223K - | 165.66M 74,387.89% | 33.39M 79.84% | -1.85M 105.54% | -126.29M 6,722.96% | -374.35M 196.41% | -505.34M 34.99% | |
net debt to ebitda | 2.17 - | 0.46 78.69% | 0.21 53.47% | -0.18 185.77% | 1.18 740.77% | 0.21 82.13% | ||
net income per share | -1.70 - | -2.41 41.87% | -4.09 69.87% | -3.37 17.65% | -2.83 15.83% | -2.22 21.82% | ||
operating cash flow per share | -0.37 - | -1.97 431.94% | -3.35 70.01% | -2.58 23.07% | 4.12 259.76% | -2.89 170.17% | ||
payables turnover | 0.11 - | 4.21 3,713.98% | ||||||
receivables turnover | 16.62 - | 9.67 41.78% | ||||||
research and ddevelopement to revenue | 2.30 - | 0.47 79.82% | ||||||
return on tangible assets | -0.45 - | -1.20 167.08% | -1.58 31.48% | -2.73 72.52% | -0.35 87.10% | -0.40 12.56% | ||
revenue per share | 0.66 - | 2.48 277.08% | ||||||
roe | -0.50 - | -3.80 658.92% | -63.12 1,562.32% | 2.67 104.23% | 0.72 72.99% | 0.44 39.64% | ||
roic | 0.31 - | 1.38 342.90% | 1.77 28.44% | 4.33 145.10% | 0.41 90.60% | 0.63 54.43% | ||
sales general and administrative to revenue | ||||||||
shareholders equity per share | 3.39 - | 0.63 81.31% | 0.06 89.78% | -1.26 2,047.39% | -3.93 211.67% | -5.09 29.54% | ||
stock based compensation to revenue | 0.90 - | 0.17 81.37% | ||||||
tangible asset value | -223K - | 166.78M 74,887.44% | 37.73M 77.38% | 4.33M 88.51% | -108.28M 2,598.32% | -353.96M 226.91% | -473.48M 33.76% | |
tangible book value per share | 3.39 - | 0.63 81.31% | 0.06 89.78% | -1.26 2,047.39% | -3.93 211.67% | -5.09 29.54% | ||
working capital | -223K - | 165.83M 74,461.88% | 77.68M 53.16% | 94.82M 22.07% | 1.99M 97.91% | 423.31M 21,225.19% | 237.81M 43.82% |
All numbers in USD (except ratios and percentages)